Industry News - Tag: RB

You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

RB’s OTC business rises by a third amid COVID-19
Premium

8 May 2020

Worldwide sales at RB’s OTC business shot up by a third on a like-for-like basis in the first quarter of 2020 as demand was boosted by the COVID-19 pandemic. RB said there had been “exceptional demand” for Mucinex in North America and for Nurofen in Europe, Australia and New Zealand.

Read the full story

Industry in brief | Pierre Fabre, Beiersdorf, RB, P&G

20 March 2020

In response to the COVID-19 pandemic, Pierre Fabre is starting to manufacture hydroalcoholic gels, Beiersdorf has stepped up production of medical grade disinfectants, RB has launched a public health information campaign, and Procter & Gamble’s (P&G’s) Vicks brand has donated USD1 million to a medic...

Read the full story

RB plans to reshape and invest GBP2 billion
Premium

3 March 2020

RB plans to reorganise around three global business units – Hygiene, Health and Nutrition – and invest GBP2 billion (USD2.5 billion) in transforming the reshaped company over the next three years. The company has also recorded a goodwill impairment charge of GBP5.04 billion relating to the Mead John...

Read the full story

People in brief | RB, Unilever, CHPA, Navamedic

5 December 2019

RB has created the new position of chief transformation officer and Unilever has appointed its first-ever chief digital and marketing officer, while the US Consumer Healthcare Products Association (CHPA) has added to its senior management team and Navamedic has a new chief financial officer.

Read the full story

Policymakers urged to develop self-care

18 November 2019

“Self-care has great potential to improve health outcomes for people and support savings for stretched healthcare budgets,” according to a new report written by the Economist Intelligence Unit and sponsored by RB.

Read the full story